Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.6B |
| 2 |
Abbott
ABT
|
+$1.29B |
| 3 |
Home Depot
HD
|
+$1.03B |
| 4 |
Devon Energy
DVN
|
+$888M |
| 5 |
PepsiCo
PEP
|
+$880M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.6B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.5B |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$1.34B |
| 4 |
Texas Instruments
TXN
|
+$1.32B |
| 5 |
Coterra Energy
CTRA
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 10.33% |
| 4 | Miscellaneous | 9.93% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3276
FinWise Bancorp
FINW
$153M
| $405K | ﹤0.01% |
27,944
+3,295
| +13% | +$49K |
2025 Q2
4 quarters
|
|
3277
Oramed Pharmaceuticals
ORMP
$180M
| $402K | ﹤0.01% |
+83,634
| New | +$333K |
2026 Q2
0 quarters
|
|
3278
FreightCar America
RAIL
$205M
| $401K | ﹤0.01% |
+41,189
| New | +$347K |
2026 Q2
0 quarters
|
|
3279
Greenwich LifeSciences
GLSI
$243M
| $401K | ﹤0.01% |
17,098
+495
| +3% | +$12K |
2024 Q2
8 quarters
|
|
3280
Richmond Mutual Bancorp
RMBI
$246M
| $400K | ﹤0.01% |
25,171
+2,646
| +12% | +$38.9K |
2025 Q2
4 quarters
|
|
3281
NI Holdings
NODK
$302M
| $398K | ﹤0.01% |
25,329
+4
| +0% | +$56 |
2017 Q2
36 quarters
|
|
3282
Douglas Elliman
DOUG
$141M
| $396K | ﹤0.01% |
223,957
+23,296
| +12% | +$41.8K |
2024 Q3
7 quarters
|
|
3283
Epsilon Energy
EPSN
$180M
| $395K | ﹤0.01% |
73,084
+20,000
| +38% | +$119K |
2025 Q2
4 quarters
|
|
3284
Vanguard Consumer Discretionary ETF
VCR
$5.83B
| $393K | ﹤0.01% |
991
-17
| -2% | -$6.61K |
2023 Q3
11 quarters
|
|
3285
Angel Oak Mortgage REIT
AOMR
$169M
| $389K | ﹤0.01% |
42,856
+1,217
| +3% | +$10.5K |
2021 Q3
19 quarters
|
|
3286
RCM Technologies
RCMT
$294M
| $386K | ﹤0.01% |
13,679
-30
| -0.2% | -$805 |
2025 Q2
4 quarters
|
|
3287
TaskUs
TASK
$746M
| $381K | ﹤0.01% |
81,501
-19,329
| -19% | -$117K |
2025 Q3
3 quarters
|
|
3288
ReposiTrak
TRAK
$143M
| $381K | ﹤0.01% |
42,330
+7,721
| +22% | +$70.6K |
2024 Q2
8 quarters
|
|
3289
Superior Group of Companies
SGC
$208M
| $379K | ﹤0.01% |
28,915
+153
| +0.5% | +$1.84K |
2024 Q2
8 quarters
|
|
3290
Espey Mfg & Electronics Corp
ESP
$172M
| $379K | ﹤0.01% |
+5,628
| New | +$357K |
2026 Q2
0 quarters
|
|
3291
Alta Equipment Group
ALTG
$207M
| $379K | ﹤0.01% |
58,530
+5,492
| +10% | +$36.8K |
2020 Q2
24 quarters
|
|
3292
Andersen Group
ANDG
$1.05B
| $377K | ﹤0.01% |
10,007
+3
| +0% | +$106 |
2026 Q1
1 quarter
|
|
3293
Lifezone Metals
LZM
$306M
| $371K | ﹤0.01% |
95,734
+24,361
| +34% | +$114K |
2024 Q2
8 quarters
|
|
3294
Nkarta
NKTX
$161M
| $371K | ﹤0.01% |
130,975
| – | – |
2020 Q3
23 quarters
|
|
3295
Traeger
COOK
$144M
| $369K | ﹤0.01% |
4,684
-3,312
| -41% | -$172K |
2021 Q3
19 quarters
|
|
3296
NexPoint Real Estate Finance
NREF
$290M
| $366K | ﹤0.01% |
23,620
+3,449
| +17% | +$51.3K |
2022 Q2
16 quarters
|
|
3297
Evolution Petroleum
EPM
$147M
| $363K | ﹤0.01% |
98,676
+9,889
| +11% | +$43.2K |
2021 Q4
18 quarters
|
|
3298
Whitehawk Therapeutics
WHWK
$201M
| $361K | ﹤0.01% |
+78,832
| New | +$328K |
2026 Q2
0 quarters
|
|
3299
Prelude Therapeutics
PRLD
$310M
| $360K | ﹤0.01% |
+67,622
| New | +$294K |
2026 Q2
0 quarters
|
|
3300
Kolibri Global Energy
KGEI
$232M
| $358K | ﹤0.01% |
71,912
+8,119
| +13% | +$43.4K |
2025 Q2
4 quarters
|
|
Similar funds
Charles Schwab's Q2 2026 Portfolio in Review
As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
- Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
- Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
- Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
- Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
- Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
- Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.